Skip to main
University-wide Navigation

Avast Therapeutics, LLC

Bioptics Technology LLC

Bluegrass Advanced Material, LLC

Joe Wyse, Chief Executive Officer,, (859)948-4716

Bluegrass Advanced Materials (BAM) is developing naturally derived antioxidant polymers that will be used in many commercial applications. Our strategy is to develop our own BAM products and supply technology to existing business to improve commercial products.

Covert Defenses, LLC

Enepret, Inc


Chase Kempinski, Chief Scientific Officer

Fission Biomedical, LLC

Based on the research of Patrick J. Casey, BVSc, Ph.D., MRCVSFission Biomedical LLC is a Kentucky based company specifically set up to commercially develop unique IP that pertains to the new growth behaviour of Eutherian Mammalian Cells. In short this new cell theory, which has been patented (see below), teaches that cells are self directional and given the appropriate conditions can regrow for tissue repair and regeneration.  The Director of the Company is Dr Padraig O’Casaigh BVSc, PhD. MRCVS

GISMO Therapeutic, Inc.

Paul Gregory, Ph.D., President, 347-251-7342

Gismo Therapeutics is developing new oral therapeutics for Alzheimer's and Parkinson's diseases, based on a new technology platform (GISMO) targeting glycosaminoglycans.

The company is funded by grants and a private investor.

Minerva Systems & Technologies

Kalyan Ganesan, Chief Technology Officer, 859.489.0156 or 859.218.6569

Minerva Systems & Technologies, LLC is an emerging technology company with expertise in navigation and guidance, satellite & wireless communications, signal processing, and embedded hardware and software design and development.

MyoAnalytics, LLC. 

Yuan Wen, Ph.D. President and Cheif Executive Officer, Phone: 859-379-8153 Email: 

MyoAnalytics is primarily a software company that provides analysis software focused on muscle tissue and cells. The company's vision is to enhance automation and precision and facilitate scientific research. MyoAnalytics currently provides advanced muscle analysis consultation services, which include deployment and maintenance of MyoVision Pro analysis software, providing ongoing training and troubleshooting, upgrading software with fixes and new analysis modules, and developing custom analysis modules upon request. 


Based on research by John Littleton / molecular pharmacology and plant genomics

Commercialized technology that enables bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's current focus is on non-toxic insecticides, CNS-acting drugs and chemotherapeutic agents.

Redleaf Biologics, LLC

Jordan Wood, COO, 205-910-0641

Based on research conducted by RedLeaf's CEO, Seth DeBolt, Ph.D.

RedLeaf is a biomanufacturing startup producing natural food colorants, antimicrobials, and antioxidants for human and livestock applications.

Signal Solutions LLC

Bruce F. O'Hara, 859.266.0964 

Signal Solutions LLC was formed in February 2009 to sell products and support research associated with their non-invasive, high-throughput sleep-wake tracking system for mice. Currently, several systems are being used in research labs around the world including an 80 cage set-up at The Jackson Laboratory (Bar Harbor, ME) as part of a large-scale NIH U54 project to perform deep phenotyping on individual mouse gene knockouts to better understand these genes and associated diseases. Signal Solutions was chosen as a primary subcontractor for this five year effort referred to as KOMP2 and supported by the International Knockout Mouse Consortium. In April 2013, Signal Solutions was awarded a 2-year Phase I NIH SBIR grant to further extent the capability of its system to track REM and nonREM sleep in addition to other behaviors. Signal Solutions also develops a variety of other hardware and software for assessing physiological variables in mice, horses, and people.

Seikowave, Inc. 

VerraGlo , LLC

W-Z Biotech

Cherry Croft

W-Z Biotech, founded in 2009 by Dr. Jay Zwischenberger, surgery, and Dr. Dongfang Wang, cardiothoracic surgery, specializes in the development of novel medical devices for cardiopulmonary surgery and hyperthermia delivery systems for lung cancer therapy.

ZDC Tech,. Ltd